DOI:
10.1055/s-00000062
Psychiatrische Praxis
LinksClose Window
References
Fedgchin M, Trivedi M, Daly E. et al.
Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: Results of a randomized, double-blind, active-controlled study (TRANSFORM-1).
Int J Neuropsychopharmacol 2019;
22: 616-630
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.